Cytokinetics General Counsel Mark Schlossberg to retire May 13, 2022

CYTOKINETICS INC

Mark A. Schlossberg, SVP Legal, General Counsel and Secretary, announced retirement.
Retirement effective May 13, 2022; departure on mutually good terms.
No replacement has been named at this time.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark A. Schlossberg

Senior Vice President, Legal, General Counsel and Secretary

CYTK · CYTOKINETICS INC

Effective: 2022-05-13
Filed: April 15, 2022, 7:59 PM ET

On April 12, 2022, Mark A. Schlossberg, Senior Vice President, Legal, General Counsel and Secretary of Cytokinetics, Incorporated, informed Cytokinetics that he would be retiring from Cytokinetics effective May 13, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark A. Schlossberg retired as Senior Vice President, Legal, General Counsel and Secretary at CYTOKINETICS INC.

Action: retired
Role: Senior Vice President, Legal, General Counsel and Secretary

Exact text from the filing

On April 12, 2022, Mark A. Schlossberg, Senior Vice President, Legal, General Counsel and Secretary of Cytokinetics, Incorporated, informed Cytokinetics that he would be retiring from Cytokinetics effective May 13, 2022.

View on SEC.gov

CYTOKINETICS INC filing history →

Source: SEC EDGAR

accession 0001171843-22-002609

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.